لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bcuglievan@mdanderson.org., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rubnitz JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA., Cooper TM; Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands; The Innovative Therapies for Children with Cancer Consortium, Paris, France., Pollard JA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guest E; Department of Pediatric Oncology, Children's Mercy, Kansas City, MO, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nunez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhalla KN; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Catueno S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fiskus W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter BZ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khazal S; Division of Transplant and Cellular Therapy, Loma Linda University School of Medicine, Loma Linda, CA, USA., Tewari P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer, Houston, TX, USA., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bourgeois W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Truong DD; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Connors J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer, Houston, TX, USA., Ludwig JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stutterheim J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Salzer E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Juul-Dam KL; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahadeo KM; Division of Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC, USA., Tasian SK; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dickson S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stein EM; Department of Leukemia, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kolb EA; Moseley Institute for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Leukemia [Leukemia] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

المؤلفون: Bhatla T; Department of Pediatrics, Children's Hospital of New Jersey at Newark Beth Israel Medical Center, Newark, New Jersey, United States., Hogan L MD; Department of Pediatrics, Stony Brook Children's, United States., Teachey DT; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, United States., Bautista F; Princess Máxima Centrum, Utrecht, Netherlands., Moppett JP; Paediatric Haematology, Bristol Royal Hospital for Children, United Kingdom., Velasco P; University Hospital Vall d´Hebron, BARCELONA, Spain., Micalizzi C; Istituto Giannina Gaslini, GENOVA, Italy., Rossig C; University Children's Hospital Münster, Muenster, Germany., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, United States., Gilad G; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel., Locatelli F; Pediatric Hematology and Immunology Department, Robert Debré University Hospital (APHP and Université de Paris Cité), France., Baruchel A; Pediatric Hematology and Immunology Department, Robert Debré University Hospital (APHP and Université de Paris Cité), France., Zwaan M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Netherlands., Bezler NS; Division of Hematology and Oncology, Connecticut Children's, Hartford, Connecticut, United States., Rubio-San-Simón A; Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Taussig D; Centre for Molecular Pathology, The Royal Marsden Hospital, Institute of Cancer Research, United Kingdom., Raetz EA; New York University Langone Medical Center, United States., Mao ZJ; Department of Laboratory Medicine, University of Washington, United States., Wood B; Department of Laboratory Medicine, University of Washington, United States., Alvarez Arias D Dr; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Krevvata M; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Nnane I; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Bandyopadhyay N; Janssen Research & Development, LLC, Raritan, New Jersey, United States., Lopez Solano L; Janssen Research & Development, LLC, Middletown, New Jersey, United States., Dennis RM; Janssen Research & Development, LLC, Lanoka Harbor, New Jersey, United States., Carson R; Janssen R&D, Springhouse, Pennsylvania, United States., Vora A; Department of Haematology, Great Ormond Street Hospital for Children, United States.

المصدر: Blood [Blood] 2024 Aug 16. Date of Electronic Publication: 2024 Aug 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

المؤلفون: Juul-Dam KL; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: krisju@rm.dk., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cooper TM; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Cuglievan B; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heidenreich O; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Kolb EA; Division of Oncology, Nemours/Alfred I. Dupont Hospital for Children, Wilmington, DE, USA., Rasouli M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

المصدر: European journal of medical genetics [Eur J Med Genet] 2023 Dec; Vol. 66 (12), pp. 104869. Date of Electronic Publication: 2023 Oct 29.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101247089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0849 (Electronic) Linking ISSN: 17697212 NLM ISO Abbreviation: Eur J Med Genet Subsets: MEDLINE

مواضيع طبية MeSH: Homeodomain Proteins*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism, Humans ; Child ; Myeloid Ecotropic Viral Integration Site 1 Protein ; Myeloid-Lymphoid Leukemia Protein/genetics ; Transcription Factors ; Cell Differentiation

المؤلفون: Paolino J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Dimitrov B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Apsel Winger B; Department of Pediatrics, Division of Hematology/Oncology, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Sandoval-Perez A; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Rangarajan AV; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Ocasio-Martinez N; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai HK; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Li Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Polonen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Dilig A; Integrated Oncology, Shelton, Connecticut., Gotti G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Kavanagh J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adhav AA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gow S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bledsoe J; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, and Department of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Cooper SL; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland., Cooper TM; Seattle Children's Hospital, Cancer and Blood Disorders Center, Seattle, Washington., Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York., Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Magee JA; Division of Pediatric Hematology/Oncology, Washington University/St. Louis Children's Hospital, St. Louis, Missouri., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Burke MJ; Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mar BG; Blueprint Medicines, Cambridge, Massachusetts., Jacobson MP; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4613-4626.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*, Humans ; Child ; Animals ; Mice ; Receptor, Platelet-Derived Growth Factor alpha/genetics ; Mutation ; Receptor Protein-Tyrosine Kinases/genetics ; T-Lymphocytes

المؤلفون: Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Nov 08; Vol. 115 (11), pp. 1246-1248.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Comment

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Benzamides* , Neoplasms*/drug therapy, Humans ; Child ; Biphenyl Compounds ; Morpholines ; DNA Helicases ; Nuclear Proteins ; Transcription Factors ; SMARCB1 Protein ; Enhancer of Zeste Homolog 2 Protein/genetics

المؤلفون: Doe-Tetteh SA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Reales D; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Noronha AM; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Wolff B; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York., Alano T; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York., Galle J; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Selcuklu SD; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Viale A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Socci ND; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Liu YL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tew WP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Graduate Program in Biophysics, Boston, Massachusetts., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Mazor RD; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel., Shpilberg O; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel.; Adelson School of Medicine, Ariel University, Ariel, Israel., Hershkovitz-Rokah O; Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel.; Translational Research Lab, Assuta Medical Center, Tel Aviv, Israel., Riancho JA; Department of Internal Medicine, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Hernandez JL; Department of Internal Medicine, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Gonzalez-Vela MC; Department of Pathology, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Buthorn JJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Wilson M; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Webber AE; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Yabe M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Petrova-Drus K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rosenblum M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Durham BH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Berger MF; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Glade Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Dogan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Soslow RA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Diamond EL; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Solit DB; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 05; Vol. 29 (13), pp. 2445-2455.

نوع المنشور: Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Journal Article; Comment

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Neoplasms, Germ Cell and Embryonal*, Humans ; Female ; Mutation ; Genomics ; Exome